We investigate the concordance, in terms of favoring the same treatment arm, between clinician-reported symptomatic adverse events (AEs) and information obtained via patient-reported outcomes (PRO) measures in cancer randomized controlled trials (RCTs).

Clinician-reported symptomatic adverse events in cancer trials: are they concordant with patient-reported outcomes?

Cottone, Francesco;Piciocchi, Alfonso;Deliu, Nina
Methodology
;
Efficace, Fabio
2019

Abstract

We investigate the concordance, in terms of favoring the same treatment arm, between clinician-reported symptomatic adverse events (AEs) and information obtained via patient-reported outcomes (PRO) measures in cancer randomized controlled trials (RCTs).
File allegati a questo prodotto
File Dimensione Formato  
Deliu_Clinician-reported_2019.pdf.pdf

solo gestori archivio

Note: Deliu_Clinician-reported_2019.pdf
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 942.03 kB
Formato Adobe PDF
942.03 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11573/1653958
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 3
  • ???jsp.display-item.citation.isi??? ND
social impact